Atrasentan in Patients With Proteinuric Glomerular Diseases
Condition(s):IgA Nephropathy; Focal Segmental Glomerulosclerosis; Alport Syndrome; Diabetic Kidney Disease; Diabetic Nephropathy Type 2; Immunoglobulin A NephropathyLast Updated:March 19, 2024Active, not recruiting